Print Print Sänd länk Bookmark and Share

22.5.2009

Genomics and High-Throughput Technologies in Biomedicine Symposium

Mauno Koivisto –centre in BioCity, Tykistökatu 6 A, Turku

The multidisciplinary fusions represented by “genomics and high-throughput technologies” have rapidly advanced our understanding of the basis of human well-being contra disease states. Genomics studies at the cellular level constitute an expanding foundation in the era of “biomedicine” aimed at advancing systems biology for medical applications. Similarly, micro-scale technologies have drastically increased speed of discovery and innovations in biomedicine. Exploitation and mastering of these principles is bound to generate a competitive opportunity in the bio-industry market, including for development of novel therapeutics and diagnostics. 


This symposium gathers world-leading scientists for the purpose of hearing and discussing their views in the research area covered by the symposium title. A particular aim is to promote future ties and cooperation among the institutions represented by the invited speakers, including from Finland, Sweden and the USA. The aim of coverage of disciplines from “bench to bedside” in medical care constitutes a forum for scientists from academic and industrial organizations, as well as those involved in forming decisions on future Finnish research strategies.


PROGRAMME


Chair: Hans Söderlund, VTT


09:00 – 9:05 Welcome, Roland Grafström, VTT

09:05 – 9:50 Genome Scale Cancer Biology, Olli Kallioniemi, VTT/FIMM

09:50 – 10:20 EMT, motility and cell contacts, Johanna Ivaska, VTT

10:20 – 10:35 Coffee break 10:35 – 11:05 Standardized NanoArray PCR (SNAP), James Willey, Department of Medicine, The University of Toledo

11:05 – 12:35 Metabolomics, Matej Oresic, VTT

12:35 – 13:05 Transgenic animals-stem cell studies, Rune Toftgård, Centre of Biotechnology, Karolinska Institutet

12:15 – 13:15 Lunch 

Chair: Rune Toftgård


13:15 – 14:00 Inflammation, Curtis Harris, Laboratory of Human Carcinogenesis, National Cancer Institute, NIH

14:00 – 14:30 Inhibition of androgen signaling, Matthias Nees, VTT

14:30 – 15:00 Stem cell dynamics, Bruce Boman, Center for Translational Cancer Research
Cancer Genetics and Stem Cell Biology, Helen F Graham Cancer Center

15:00 – 15:30 Coffee break

15:30 – 16:00 Conflicts between molecular classification and pathology, Edward Gabrielson, Department of Pathology, John Hopkins Cancer Center, John Hopkins University School of Medicine

16:00– 16:30 Programmed cell death: severe congenital neutropenia or Kostmann disease, Bengt Fadeel, Institut of Enviromental Medicine, Karolinska Institutet

16:30 – 17:00 Obesity, viral-induced, Martin Schalling, Department for Molecular Medicine and Surgery, Karolinska Institutet


Registrations


The seminar is is free of charge.


Organized by VTT in scientific cooperation with University of Turku and Åbo Akademi/BTK and Karolinska Institutet.